Fraud and Abuse in the Sales and Marketing of Drugs
|Event Date/Time: Jul 09, 2004|
Aggressive and rapid enforcement activity continues across the pharmaceutical manufacturing community. Enforcers are more vigilant than ever in attempting to curb questionable sales and marketing practices of pharmaceutical companies. The means employed by enforcers to include companies in the net of prosecution continue to be creative and challenging to defend. Moreover, the plaintiffs’ bar has followed in the wake of the criminal prosecutions with civil suits seeking significant damages.
Each company must not only ensure that its fraud and abuse compliance strategy is effective, it must constantly monitor and maintain it in an effort to avoid being caught up in the ever-widening net of prosecution.
As the need for ongoing and bullet-proof compliance techniques increases, even the most sophisticated corporate counsel, sales and marketing executive and compliance officer needs an up-to-the-minute understanding of the latest developments on the enforcement front... and forecast for tomorrow's enforcement agenda. American Conference Institute's Fourth National Forum on Fraud and Abuse in the Sales and Marketing of Drugs will provide you with the most sophisticated and comprehensive understanding of the most difficult and costly issues - from the front lines.
This year's forum features insights from experienced prosecutors from the most active jurisdictions, who will highlight the latest criminal and civil actions…and what you need to learn from those prosecutions to minimize your company's exposure. In-house counsel from Pfizer, Bayer, Schering, Sanofi, Wyeth and Solvay will share their insights on creating and maintaining effective compliance strategies.